Seth Klarman's position in Jazz Pharmaceuticals plc is currently worth $92.3 Million. That's 2.96% of their equity portfolio (9th largest holding). The investor owns 1.36% of the outstanding Jazz Pharmaceuticals plc stock. The investor's estimated purchase price is $117 Million, resulting in a loss of 21%.